To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene DHX30TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
361 representative clones for gene DHX30 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BX449007 fetal liver, Liver .a -8 to 958 21 to 978   tiling clone,   958/978
(97 %)
20 diff
(98.0 %id)
BX449006 fetal liver, Liver .a 2719 to 3703 983 to 1   tiling clone,   983/988
(99 %)
8 diff
(99.2 %id)
NM_138615.2   .b 1 to 4086 1 to 4086 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 4086/4086
(100 %)
0 diff
(100 %id)
DB454748 testis .b 20 to 495 1 to 476   tiling clone,   476/476
(100 %)
0 diff
(100 %id)
BC028405 Brain, hippocampus .b 227 to 4083 8 to 3863 T159A P175Q L265V Q518K S600C ... available from MGC, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 3856/3856
(100 %)
8 diff
(99.8 %id)
DA277537 corpus callosum .b 231 to 795 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB268156 uterus .b 231 to 728 2 to 499   capped   498/498
(100 %)
0 diff
(100 %id)
AL555884 placenta .b 240 to 1174 1 to 933       933/933
(100 %)
8 diff
(99.2 %id)
BI910096 leukocyte .b 246 to 955 1 to 713       713/713
(100 %)
15 diff
(97.9 %id)
BC020126 Lymph, lymphoma .b 253 to 4083 1 to 3831 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 3831/3831
(100 %)
0 diff
(100 %id)
CN390142 embryonic stem cells, cell lines H1, H7, andH9 .b 254 to 946 1 to 695       695/695
(100 %)
5 diff
(99.3 %id)
BF794552 lymph, lymphoma, cell line .b 254 to 1072 1 to 819       819/1132
(72 %)
35 diff
(97.0 %id)
CN390143 embryonic stem cells, DMSO-treated H9 cellline .b 255 to 443 1 to 189       189/189
(100 %)
0 diff
(100 %id)
CD358712 testis .b 255 to 977 1 to 731       731/915
(79 %)
23 diff
(97.5 %id)
BU594473 mixed (pool of 40 RNAs) .b 271 to 1012 1 to 744       744/848
(87 %)
20 diff
(97.7 %id)
AB020697 brain .b 284 to 4083 1 to 3800 exact available from KIAA,   3800/3800
(100 %)
0 diff
(100 %id)
BM904372 lymph, lymphoma, cell line .b 291 to 1182 1 to 911       910/1006
(90 %)
25 diff
(97.6 %id)
BU193557 leiomyosarcoma, uterus .b 294 to 1029 1 to 738       738/943
(78 %)
15 diff
(98.5 %id)
BM476976 leiomyosarcoma, uterus .b 299 to 1206 1 to 918       918/1115
(82 %)
35 diff
(96.9 %id)
AI815600 brain, frontal lobe .b 361 to 710 1 to 350       350/350
(100 %)
0 diff
(100 %id)
AI928932 brain, frontal lobe .b 361 to 779 1 to 418       418/418
(100 %)
1 diff
(99.8 %id)
DA467707 cord Blood .b 534 to 1107 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BX282025 lymph, lymphoma, cell line .b 578 to 1062 1 to 485       485/485
(100 %)
0 diff
(100 %id)
BM478224 lymph, lymphoma, cell line .b 578 to 1518 1 to 945       945/1037
(91 %)
18 diff
(98.3 %id)
BM477540 lymph, lymphoma, cell line .b 627 to 1408 1 to 788       788/1068
(73 %)
27 diff
(97.5 %id)
BF981852 duodenal adenocarcinoma, cell line, small intestine .b 663 to 1415 1 to 759       759/972
(78 %)
23 diff
(97.7 %id)
BG911254 anaplastic oligodendroglioma with 1p/19qloss, brain .b 676 to 1363 1 to 687       687/687
(100 %)
9 diff
(98.7 %id)
CN390159 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 738 to 1403 1 to 666       666/666
(100 %)
2 diff
(99.7 %id)
BG748455 eye, normal pigmented retinal epithelium .b 814 to 1554 1 to 736       736/736
(100 %)
7 diff
(99.1 %id)
BG106308 lymph, lymphoma, cell line .b 900 to 1604 1 to 709   AAA   709/1009
(70 %)
11 diff
(99.0 %id)
BF314883 brain, neuroblastoma .b 1024 to 1752 1 to 726       726/870
(83 %)
23 diff
(97.4 %id)
BI196226 brain, neuroblastoma .b 1024 to 1640 1 to 617       617/617
(100 %)
0 diff
(100 %id)
BQ707490 Spleen .b 1043 to 1933 1 to 892       892/894
(99 %)
11 diff
(98.8 %id)
BM800978 melanotic melanoma, skin .b 1092 to 1799 1 to 708       708/1036
(68 %)
9 diff
(99.2 %id)
CO402182 Chondrosarcoma Lung Metastasis cell lines, lung .b 1112 to 1780 1 to 665       665/844
(78 %)
11 diff
(98.7 %id)
CO246559 Chondrosarcoma Lung Metastasis cell lines, lung .b 1149 to 1893 44 to 787       744/795
(93 %)
15 diff
(98.2 %id)
BQ071124 brain, neuroblastoma, cell line .b 1216 to 2102 1 to 899       899/1008
(89 %)
20 diff
(98.1 %id)
BF312690 brain, neuroblastoma .b 1226 to 1969 1 to 735       735/920
(79 %)
14 diff
(98.5 %id)
BE313325 brain, neuroblastoma .b 1281 to 2029 1 to 752       752/876
(85 %)
16 diff
(98.2 %id)
BG753442 eye, normal pigmented retinal epithelium .b 1292 to 2086 1 to 792       792/889
(89 %)
23 diff
(97.5 %id)
TI_59386539   .b 1440 to 2246 61 to 871       811/812
(99 %)
11 diff
(98.7 %id)
BM008822 adenocarcinoma, Pancreas .b 1441 to 2246 1 to 810       810/811
(99 %)
11 diff
(98.7 %id)
TI_154197383   .b 1473 to 2369 110 to 1003       894/979
(91 %)
26 diff
(97.4 %id)
BF237602 leiomyosarcoma cell line, uterus .b 1648 to 2432 1 to 783       783/792
(98 %)
11 diff
(98.7 %id)
BU190572 melanotic melanoma, cell line, skin .b 1688 to 2500 22 to 841       818/872
(93 %)
15 diff
(98.3 %id)
BQ676354 melanotic melanoma, cell line, skin .b 1688 to 2530 13 to 860       848/941
(90 %)
19 diff
(98.0 %id)
BQ681788 melanotic melanoma, cell line, skin .b 1688 to 2532 22 to 871       850/948
(89 %)
23 diff
(97.6 %id)
BQ678124 melanotic melanoma, cell line, skin .b 1688 to 2632 22 to 971       950/972
(97 %)
25 diff
(97.5 %id)
BQ877506 melanotic melanoma, cell line, skin .b 1692 to 2482 1 to 796       796/869
(91 %)
6 diff
(99.4 %id)
BU179205 melanotic melanoma, cell line, skin .b 1692 to 2596 1 to 908       908/914
(99 %)
11 diff
(98.8 %id)
BU161098 melanotic melanoma, cell line, skin .b 1692 to 2540 1 to 850       850/932
(91 %)
10 diff
(99.0 %id)
BQ682063 melanotic melanoma, cell line, skin .b 1692 to 2412 1 to 722       722/958
(75 %)
15 diff
(98.5 %id)
BQ684531 melanotic melanoma, cell line, skin .b 1692 to 2535 1 to 846       846/925
(91 %)
19 diff
(98.0 %id)
BQ684193 melanotic melanoma, cell line, skin .b 1692 to 2491 1 to 803       803/932
(86 %)
14 diff
(98.5 %id)
BU190883 melanotic melanoma, cell line, skin .b 1692 to 2436 1 to 745       745/858
(86 %)
6 diff
(99.4 %id)
BQ679373 melanotic melanoma, cell line, skin .b 1692 to 2613 1 to 925       925/925
(100 %)
17 diff
(98.2 %id)
BX441027 brain, fetal brain .b 1753 to 2715 1 to 959       959/959
(100 %)
5 diff
(99.5 %id)
BE740533 adenocarcinoma cell line, ovary .b 1779 to 2564 1 to 778       778/987
(78 %)
17 diff
(98.3 %id)
CA487784   .b 1809 to 2715 1 to 918       918/1006
(91 %)
14 diff
(98.7 %id)
BM710474 eye, RPE and Choroid .b 1822 to 2312 1 to 491       491/491
(100 %)
0 diff
(100 %id)
DR763115 embryonic stem .b 1872 to 2529 1 to 658       658/658
(100 %)
1 diff
(99.9 %id)
CR985154 T-Lymphocytes .b 1895 to 2451 1 to 557       557/559
(99 %)
1 diff
(99.9 %id)
CA454590   .b 1909 to 2713 1 to 812       812/897
(90 %)
8 diff
(99.2 %id)
BQ052997 blood, natural killer cells, cell line .b 1941 to 2633 1 to 700       700/1064
(65 %)
25 diff
(97.7 %id)
BE384979 melanotic melanoma, skin .b 1969 to 2615 1 to 646       646/649
(99 %)
2 diff
(99.7 %id)
U69564 whole brain .b 2028 to 4083 1 to 2054   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 2054/2054
(100 %)
6 diff
(99.8 %id)
CR992145 T-Lymphocytes .b 2092 to 2954 1 to 863       863/863
(100 %)
8 diff
(99.1 %id)
BG765647 melanotic melanoma, high MDR (cell line), skin .b 2168 to 2994 1 to 829       829/829
(100 %)
4 diff
(99.6 %id)
CF272423 Brain glioblastoma .b 2172 to 2957 1 to 791       789/870
(90 %)
5 diff
(99.5 %id)
BE710163 head_neck .b 2186 to 2416 231 to 1       231/231
(100 %)
0 diff
(100 %id)
BX103993 whole brain .b 2215 to 2748 1 to 534       534/534
(100 %)
0 diff
(100 %id)
BU155002 melanotic melanoma, skin .b 2220 to 2993 1 to 780       780/902
(86 %)
8 diff
(99.2 %id)
BQ316378 colon .b 2243 to 2864 1 to 622       622/622
(100 %)
0 diff
(100 %id)
AL135247 melanoma (MeWo cell line) .b 2271 to 2540 1 to 270       270/270
(100 %)
0 diff
(100 %id)
BE740552 adenocarcinoma cell line, ovary .b 2276 to 3128 1 to 841       841/978
(85 %)
17 diff
(98.3 %id)
BQ935053 epidermoid carcinoma, cell line, lung .b 2313 to 3248 1 to 944       942/945
(99 %)
17 diff
(98.3 %id)
BQ922537 epidermoid carcinoma, cell line, lung .b 2313 to 3195 1 to 894       894/937
(95 %)
17 diff
(98.2 %id)
CV802680 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 2317 to 3045 1 to 715       717/827
(86 %)
14 diff
(98.4 %id)
BG029791 breast, mammary adenocarcinoma, cell line .b 2318 to 3010 1 to 693       693/1057
(65 %)
7 diff
(99.4 %id)
F06591 brain, total brain .b 2321 to 2690 1 to 369       369/369
(100 %)
1 diff
(99.8 %id)
BU174270 melanotic melanoma, cell line, skin .b 2362 to 3130 25 to 793       769/975
(78 %)
19 diff
(98.1 %id)
BQ717098 sympathetic trunk .b 2363 to 3176 1 to 827       827/834
(99 %)
18 diff
(97.9 %id)
BU190535 melanotic melanoma, cell line, skin .b 2370 to 3176 1 to 818       818/844
(96 %)
13 diff
(98.5 %id)
BQ892619 melanotic melanoma, cell line, skin .b 2370 to 3250 1 to 885       885/885
(100 %)
9 diff
(99.0 %id)
BQ676644 melanotic melanoma, cell line, skin .b 2370 to 3190 1 to 828       828/973
(85 %)
17 diff
(98.3 %id)
BU185568 melanotic melanoma, cell line, skin .b 2370 to 3195 1 to 831       831/949
(87 %)
15 diff
(98.5 %id)
BQ683654 melanotic melanoma, cell line, skin .b 2370 to 3112 1 to 742       742/926
(80 %)
15 diff
(98.4 %id)
BQ681597 melanotic melanoma, cell line, skin .b 2373 to 3206 19 to 855       837/920
(90 %)
30 diff
(96.8 %id)
CA489592   .b 2415 to 3260 1 to 849       847/851
(99 %)
5 diff
(99.5 %id)
BM917113 blood, natural killer cells, cell line .b 2443 to 3355 1 to 921       921/1092
(84 %)
11 diff
(99.0 %id)
BQ052874 blood, natural killer cells, cell line .b 2443 to 3336 1 to 906       906/1051
(86 %)
27 diff
(97.5 %id)
CD673957 eye, lens .b 2458 to 2843 1 to 386     Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 386/386
(100 %)
0 diff
(100 %id)
BG679886 skin, squamous cell carcinoma .b 2483 to 3190 1 to 706       706/706
(100 %)
4 diff
(99.5 %id)
BM786190 stomach .b 2484 to 3075 1 to 592       592/592
(100 %)
0 diff
(100 %id)
TI_1948135353   .b 2503 to 3195 129 to 824       696/1235
(56 %)
18 diff
(98.6 %id)
TI_1948135354   .b 2503 to 3197 127 to 820       694/1270
(54 %)
17 diff
(98.7 %id)
TI_1948135716   .b 2503 to 3166 132 to 802       671/1310
(51 %)
29 diff
(97.8 %id)
TI_1948136066   .b 2503 to 3197 125 to 821       697/1255
(55 %)
23 diff
(98.2 %id)
TI_1948136067   .b 2503 to 3190 129 to 817       689/1289
(53 %)
19 diff
(98.6 %id)
TI_1948136418   .b 2503 to 3193 126 to 816       691/1217
(56 %)
10 diff
(99.2 %id)
BC014237 Uterus, leiomyosarcoma .b 2506 to 4083 1 to 1578   available from MGC, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1578/1578
(100 %)
1 diff
(100.0 %id)
BI117168 lung, small cell carcinoma .b 2514 to 3321 1 to 803       803/882
(91 %)
22 diff
(97.6 %id)
BG387511 embryonal carcinoma, cell line, testis .b 2521 to 3290 1 to 759       759/940
(80 %)
15 diff
(98.5 %id)
CD514089 brain, Pituitary .b 2583 to 3411 1 to 841       841/930
(90 %)
25 diff
(97.4 %id)
BM802985 duodenal adenocarcinoma, cell line, small intestine .b 2610 to 3352 1 to 749       749/1099
(68 %)
17 diff
(98.5 %id)
BI256017 cervical carcinoma cell line, cervix .b 2627 to 3298 1 to 672       672/672
(100 %)
1 diff
(99.9 %id)
AW250316 lung, small cell carcinoma .b 2639 to 3103 10 to 474     Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 465/474
(98 %)
7 diff
(98.6 %id)
BE741712 adenocarcinoma cell line, ovary .b 2640 to 3514 1 to 874       874/945
(92 %)
28 diff
(97.1 %id)
BM708493 eye, RPE and Choroid .b 2650 to 2952 1 to 301     Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 301/301
(100 %)
3 diff
(99.1 %id)
BE906531 epithelioid carcinoma, Pancreas .b 2658 to 3420 1 to 760       760/765
(99 %)
11 diff
(98.6 %id)
BM700068 eye, lens .b 2674 to 3254 1 to 581     Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 581/581
(100 %)
1 diff
(99.9 %id)
BI117491 lung, small cell carcinoma .b 2693 to 3486 1 to 786       786/797
(98 %)
13 diff
(98.4 %id)
BM709299 eye, optic nerve .b 2734 to 3073 1 to 340       340/340
(100 %)
0 diff
(100 %id)
BQ053840 blood, natural killer cells, cell line .b 2774 to 3592 1 to 825       825/956
(86 %)
8 diff
(99.2 %id)
CN390141 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2833 to 3278 1 to 446       446/446
(100 %)
0 diff
(100 %id)
CX783646 human embryonic stem cells .b 2837 to 3618 1 to 781       781/781
(100 %)
1 diff
(99.9 %id)
BQ716979 sympathetic trunk .b 2864 to 3709 1 to 859       859/861
(99 %)
24 diff
(97.3 %id)
BQ069201 brain, neuroblastoma, cell line .b 2866 to 3760 1 to 896       896/1018
(88 %)
9 diff
(99.2 %id)
BM473514 melanotic melanoma, skin .b 2884 to 3872 8 to 1004       997/1105
(90 %)
24 diff
(97.9 %id)
CA489882   .b 2884 to 3752 26 to 899       874/925
(94 %)
17 diff
(98.2 %id)
BQ943356 brain, neuroblastoma, cell line .b 2914 to 3842 1 to 931       931/937
(99 %)
19 diff
(98.0 %id)
BU171814 melanotic melanoma, skin .b 2919 to 3753 16 to 861       846/861
(98 %)
23 diff
(97.4 %id)
AA310536   .b 2935 to 3223 1 to 289       289/289
(100 %)
0 diff
(100 %id)
TI_57177245   .b 2935 to 3742 26 to 831       806/831
(96 %)
14 diff
(98.4 %id)
BI831017 brain, medulla .b 2937 to 3742 1 to 805       805/805
(100 %)
9 diff
(98.9 %id)
BE294282 muscle, rhabdomyosarcoma .b 2977 to 3623 1 to 646       646/647
(99 %)
7 diff
(99.0 %id)
BI092474 cervix .b 3012 to 3734 1 to 723       723/724
(99 %)
3 diff
(99.6 %id)
BQ644225 hepatocellular carcinoma, cell line, Liver .b 3038 to 3760 12 to 735       724/873
(82 %)
18 diff
(98.0 %id)
BQ647505 hepatocellular carcinoma, cell line, Liver .b 3038 to 3998 9 to 974       966/974
(99 %)
20 diff
(98.0 %id)
BQ647260 hepatocellular carcinoma, cell line, Liver .b 3038 to 3874 8 to 845       838/881
(95 %)
16 diff
(98.2 %id)
BQ650491 hepatocellular carcinoma, cell line, Liver .b 3038 to 3874 9 to 853       845/914
(92 %)
16 diff
(98.3 %id)
BQ649224 hepatocellular carcinoma, cell line, Liver .b 3038 to 3874 8 to 850       843/943
(89 %)
29 diff
(97.0 %id)
BQ651310 hepatocellular carcinoma, cell line, Liver .b 3038 to 3874 8 to 849       842/996
(84 %)
21 diff
(97.9 %id)
BQ653267 hepatocellular carcinoma, cell line, Liver .b 3048 to 3760 1 to 714       714/931
(76 %)
10 diff
(99.0 %id)
BQ648635 hepatocellular carcinoma, cell line, Liver .b 3048 to 3713 1 to 665       665/956
(69 %)
25 diff
(97.4 %id)
BQ649965 hepatocellular carcinoma, cell line, Liver .b 3048 to 3925 1 to 891       891/904
(98 %)
42 diff
(95.4 %id)
BQ645225 hepatocellular carcinoma, cell line, Liver .b 3048 to 3872 1 to 837       837/858
(97 %)
20 diff
(97.7 %id)
BQ645880 hepatocellular carcinoma, cell line, Liver .b 3048 to 3805 1 to 766       766/904
(84 %)
8 diff
(99.2 %id)
BQ653936 hepatocellular carcinoma, cell line, Liver .b 3048 to 3952 1 to 914       914/915
(99 %)
31 diff
(96.7 %id)
BQ646423 hepatocellular carcinoma, cell line, Liver .b 3048 to 4000 1 to 955       955/956
(99 %)
15 diff
(98.5 %id)
BQ876525 hepatocellular carcinoma, cell line, Liver .b 3048 to 3869 1 to 825       825/861
(95 %)
8 diff
(99.1 %id)
CD674466 eye, lens .b 3070 to 3653 1 to 584     Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 584/584
(100 %)
0 diff
(100 %id)
CD674616 eye, lens .b 3070 to 3159 1 to 90       90/90
(100 %)
0 diff
(100 %id)
AL578271 placenta .b 3084 to 4049 960 to 1       960/960
(100 %)
14 diff
(98.6 %id)
TI_154135335   .b 3084 to 4083 1074 to 89   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 988/1026
(96 %)
33 diff
(96.8 %id)
CB159844 Liver .b 3133 to 3737 1 to 605       605/605
(100 %)
0 diff
(100 %id)
AW176593 colon .b 3169 to 3427 259 to 1       259/259
(100 %)
0 diff
(100 %id)
BU192945 eye, retinoblastoma .b 3177 to 4029 1 to 867       867/889
(97 %)
35 diff
(96.1 %id)
BI160809 epithelioid carcinoma cell line, Pancreas .b 3201 to 3890 1 to 692       692/952
(72 %)
5 diff
(99.5 %id)
TI_154135353   .b 3224 to 4083 929 to 77   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 853/984
(86 %)
17 diff
(98.3 %id)
BX455037 brain, fetal brain .b 3227 to 4071 869 to 9       861/894
(96 %)
26 diff
(97.1 %id)
CD674326 eye, lens .b 3246 to 3684 1 to 439       439/439
(100 %)
0 diff
(100 %id)
CN390152 embryonic stem cells, cell lines H1, H7, andH9 .b 3286 to 4029 11 to 754       744/754
(98 %)
7 diff
(99.1 %id)
BM707362 eye, eye anterior segment .b 3309 to 3708 9 to 408   fully sequenced, Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 400/408
(98 %)
1 diff
(99.8 %id)
BG764992 melanotic melanoma, high MDR (cell line), skin .b 3334 to 4063 1 to 731       731/732
(99 %)
5 diff
(99.4 %id)
BQ233869 epithelioid carcinoma, Pancreas .b 3351 to 4083 756 to 22   AAA Submitted on the opposite strand 735/875
(84 %)
7 diff
(99.2 %id)
AI697628 carcinoid, lung .b 3374 to 3819 446 to 1       446/446
(100 %)
0 diff
(100 %id)
BF341878 brain, glioblastoma with EGFR amplification .b 3409 to 4084 1 to 677   AAA   677/691
(97 %)
3 diff
(99.6 %id)
TI_149285548   .b 3412 to 4083 756 to 85   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 672/672
(100 %)
1 diff
(99.9 %id)
TI_154023099   .b 3423 to 4083 750 to 90   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 661/661
(100 %)
1 diff
(99.9 %id)
BU608014 Human Lung Epithelial cells, lung .b 3426 to 4083 676 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 658/658
(100 %)
0 diff
(100 %id)
BM971467 lung .b 3497 to 4083 605 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 587/587
(100 %)
0 diff
(100 %id)
BU737869 eye, lens .b 3497 to 4083 605 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 587/587
(100 %)
1 diff
(99.9 %id)
CA439325 lung, Metastatic Chondrosarcoma .b 3497 to 4083 605 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 587/587
(100 %)
0 diff
(100 %id)
CD368247 Alveolar Macrophage, lung .b 3505 to 4086 600 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 582/582
(100 %)
0 diff
(100 %id)
CA426688 cell lines, Chondrosarcoma .b 3506 to 4083 596 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 578/578
(100 %)
0 diff
(100 %id)
AI815879 brain, frontal lobe .b 3545 to 4084 548 to 9       540/548
(98 %)
0 diff
(100 %id)
BE349448 malignant melanoma, metastatic to lymphnode, skin .b 3549 to 4081 533 to 1       533/533
(100 %)
0 diff
(100 %id)
BU732445 eye, optic nerve .b 3550 to 4078 552 to 24   AAA   529/534
(99 %)
0 diff
(100 %id)
CB217755 mandible, pooled .b 3575 to 4083 1 to 509   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 509/509
(100 %)
0 diff
(100 %id)
AW071607 pooled germ cell tumors .b 3592 to 4083 492 to 1       492/492
(100 %)
0 diff
(100 %id)
AW006629 colon .b 3593 to 4084 492 to 1       492/492
(100 %)
0 diff
(100 %id)
AW029278 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 3593 to 4084 492 to 1       492/492
(100 %)
0 diff
(100 %id)
DB527551 testis .b 3616 to 4083 1 to 468     Submitted on the opposite strand 468/468
(100 %)
0 diff
(100 %id)
CD673956 eye, lens .b 3621 to 4079 476 to 18   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 459/459
(100 %)
1 diff
(99.8 %id)
DB522729 testis .b 3622 to 4077 1 to 456     Submitted on the opposite strand 456/456
(100 %)
0 diff
(100 %id)
AW250994 lung, small cell carcinoma .b 3625 to 4083 469 to 11   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 459/459
(100 %)
0 diff
(100 %id)
BQ008273 Chondrosarcoma, Left Pelvis .b 3626 to 4083 476 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 458/458
(100 %)
0 diff
(100 %id)
CN390156 embryonic stem cells, DMSO-treated H9 cellline .b 3638 to 4079 1 to 442       442/442
(100 %)
0 diff
(100 %id)
AI929185 brain, frontal lobe .b 3651 to 4084 442 to 9       434/442
(98 %)
0 diff
(100 %id)
BQ188007 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 3676 to 4083 1 to 408   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 408/408
(100 %)
0 diff
(100 %id)
BM673473 eye, eye anterior segment .b 3678 to 4083 424 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 406/406
(100 %)
2 diff
(99.6 %id)
CN390161 embryonic stem cells, DMSO-treated H9 cellline .b 3683 to 3989 1 to 307       307/307
(100 %)
0 diff
(100 %id)
BM671932 eye, RPE and Choroid .b 3684 to 4078 418 to 24   AAA   395/400
(98 %)
3 diff
(99.3 %id)
AJ710636 heart .b 3699 to 4083 1 to 385   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 385/385
(100 %)
0 diff
(100 %id)
BG331948 large cell carcinoma, lung .b 3723 to 4083 1 to 361   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 361/361
(100 %)
0 diff
(100 %id)
CB217754 mandible, pooled .b 3727 to 4083 401 to 45   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 357/357
(100 %)
0 diff
(100 %id)
BG759170 B-cells, primary B-cells from tonsils (cell line) .b 3739 to 4083 1 to 345   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 345/345
(100 %)
0 diff
(100 %id)
CD674465 eye, lens .b 3757 to 4082 353 to 28   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 326/330
(98 %)
3 diff
(99.1 %id)
AI244327 Kidney .b 3765 to 4084 320 to 1       320/320
(100 %)
0 diff
(100 %id)
Z39572 brain, total brain .b 3772 to 4083 311 to 1       311/311
(100 %)
1 diff
(99.7 %id)
BU730799 eye, RPE and Choroid .b 3803 to 4083 299 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 281/281
(100 %)
0 diff
(100 %id)
AI648464 ovary, tumor, 5 pooled (see description) .b 3834 to 4084 251 to 1       251/251
(100 %)
0 diff
(100 %id)
DV459028 cochlea, ear .b 3918 to 4035 118 to 1     Submitted on the opposite strand 118/118
(100 %)
0 diff
(100 %id)
AA016091 eye, retina .b 3957 to 4077 121 to 1     Submitted on the opposite strand 121/121
(100 %)
0 diff
(100 %id)
AI344056 colon, colon tumor, RER+ .b 3993 to 4082 90 to 1       90/90
(100 %)
0 diff
(100 %id)
NM_014966.3   .c 1 to 4115 1 to 4115 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 4115/4115
(100 %)
0 diff
(100 %id)
DB444698 testis .c 153 to 575 1 to 423   tiling clone,   423/423
(100 %)
3 diff
(99.3 %id)
DB453077 testis .c 172 to 674 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
AK291266   .c 226 to 4112 1 to 3887 I518T G742D     3887/3887
(100 %)
4 diff
(99.9 %id)
DB462117 testis .c 227 to 710 1 to 485       485/489
(99 %)
3 diff
(99.4 %id)
DA757687   .c 227 to 780 2 to 556   capped   555/557
(99 %)
3 diff
(99.5 %id)
DB445899 testis .c 247 to 710 1 to 462       462/465
(99 %)
3 diff
(99.4 %id)
DB458920 testis .c 247 to 701 1 to 455       455/455
(100 %)
0 diff
(100 %id)
BI832242 brain, medulla .c 251 to 788 1 to 540       540/542
(99 %)
10 diff
(98.2 %id)
TI_57176439   .c 251 to 788 1 to 540       540/542
(99 %)
10 diff
(98.2 %id)
BC038417 Brain, adult medulla .c 254 to 4112 1 to 3859 exact available from MGC, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 3859/3859
(100 %)
1 diff
(100.0 %id)
BC015029 Uterus, leiomyosarcoma .c 255 to 4112 1 to 3858 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 3858/3858
(100 %)
0 diff
(100 %id)
BM146460 leukopheresis .c 255 to 600 1 to 346       346/346
(100 %)
3 diff
(99.2 %id)
DB463216 hippocampus .c 275 to 623 1 to 348       348/348
(100 %)
12 diff
(96.6 %id)
BE886425 leiomyosarcoma, uterus .c 276 to 803 1 to 533       531/700
(75 %)
9 diff
(98.8 %id)
CA391835 eye, RPE/choroid .c 302 to 661 51 to 410       360/410
(87 %)
8 diff
(98.1 %id)
DB459339 testis .c 558 to 1039 1 to 482       482/482
(100 %)
0 diff
(100 %id)
DB461673 testis .c 558 to 1033 1 to 476       476/476
(100 %)
1 diff
(99.8 %id)
DB452025 testis .d 1 to 497 1 to 497   tiling clone,   497/497
(100 %)
1 diff
(99.8 %id)
BG723223 testis .d 16 to 629 1 to 616       616/706
(87 %)
23 diff
(96.8 %id)
DB457282 testis .d 31 to 499 1 to 469       469/469
(100 %)
0 diff
(100 %id)
DA454883 tongue, tumor tissue .d 41 to 601 2 to 562   tiling clone, capped   561/561
(100 %)
1 diff
(99.9 %id)
DA874497 Prostate .d 52 to 462 2 to 412   capped   411/411
(100 %)
0 diff
(100 %id)
AI971425 pooled germ cell tumors .d 100 to 638 538 to 1       538/538
(100 %)
16 diff
(97.1 %id)
BI562729 testis .d 545 to 1367 1 to 823   tiling clone,   821/936
(87 %)
52 diff
(94.5 %id)
TI_44351232   .d 547 to 1367 136 to 956       819/1069
(76 %)
50 diff
(95.4 %id)
DR000672 fetal brain .d 602 to 1168 1 to 569       569/569
(100 %)
7 diff
(98.8 %id)
BG717956 testis .d 607 to 1330 1 to 722       722/723
(99 %)
11 diff
(98.5 %id)
BM172229 testis .d 607 to 1176 1 to 580       536/580
(92 %)
13 diff
(97.8 %id)
BI562582 testis .d 607 to 1292 1 to 683       683/683
(100 %)
7 diff
(99.0 %id)
TI_44350998   .d 608 to 1292 133 to 814       682/814
(83 %)
10 diff
(98.8 %id)
DB081626 testis .d 611 to 1119 2 to 510   capped   509/509
(100 %)
2 diff
(99.7 %id)
DA622441 Kidney .d 613 to 1149 2 to 538   capped   537/537
(100 %)
2 diff
(99.7 %id)
DA713842   .d 613 to 1160 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA692583   .d 617 to 1182 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DB450707 testis .d 618 to 1081 1 to 464       464/465
(99 %)
8 diff
(98.3 %id)
BG717465 testis .d 620 to 1389 9 to 777       769/798
(96 %)
36 diff
(95.5 %id)
BI462964 testis .d 622 to 1320 1 to 705       702/705
(99 %)
25 diff
(96.5 %id)
BI463314 testis .d 622 to 1320 1 to 701       701/701
(100 %)
14 diff
(98.1 %id)
CN357999 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 624 to 1002 1 to 379       379/379
(100 %)
1 diff
(99.8 %id)
CD109598 Human Placenta, placenta .d 625 to 1300 28 to 708       681/755
(90 %)
11 diff
(98.6 %id)
CF994324 Human Placenta, placenta .d 625 to 1298 29 to 701       673/714
(94 %)
13 diff
(98.2 %id)
BU553757 ovary, teratocarcinoma, cell line .d 628 to 1287 33 to 697       665/1036
(64 %)
17 diff
(98.4 %id)
DA239801 brain .d 629 to 1162 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
BQ070878 brain, neuroblastoma, cell line .d 629 to 1508 1 to 879   tiling clone,   879/1016
(86 %)
13 diff
(98.8 %id)
CN357995 embryonic stem cells, cell lines H1, H7, andH9 .d 630 to 1087 1 to 459       459/459
(100 %)
7 diff
(98.5 %id)
CN357997 embryonic stem cells, cell lines H1, H7, andH9 .d 630 to 1048 1 to 419       419/419
(100 %)
1 diff
(99.8 %id)
BG335538 choriocarcinoma, placenta .d 631 to 1294 1 to 662       662/663
(99 %)
10 diff
(98.5 %id)
DA701200   .d 635 to 1087 2 to 454   capped   453/467
(97 %)
2 diff
(99.6 %id)
DA306360 hippocampus .d 637 to 1184 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
N26265 melanocyte .d 640 to 1065 1 to 425     Submitted on the opposite strand 425/425
(100 %)
13 diff
(97.0 %id)
AA015964 eye, retina .d 640 to 1037 1 to 397     Submitted on the opposite strand 397/397
(100 %)
12 diff
(97.0 %id)
AI097043 uterus .d 640 to 1132 1 to 493     Submitted on the opposite strand 493/493
(100 %)
3 diff
(99.4 %id)
AI568540 anaplastic oligodendroglioma, brain .d 640 to 1156 1 to 517     Submitted on the opposite strand 517/518
(99 %)
2 diff
(99.7 %id)
AW024763 Kidney .d 640 to 1162 1 to 522     Submitted on the opposite strand 522/522
(100 %)
1 diff
(99.9 %id)
AW207396   .d 641 to 1054 1 to 414     Submitted on the opposite strand 414/414
(100 %)
2 diff
(99.6 %id)
BI545634 brain, hippocampus .d 642 to 1367 1 to 715       715/718
(99 %)
27 diff
(96.3 %id)
TI_44165714   .d 650 to 1367 150 to 856       707/859
(82 %)
26 diff
(97.0 %id)
BM553968 brain, medulla .d 653 to 1396 1 to 746       746/1039
(71 %)
26 diff
(97.5 %id)
BF431634 Kidney .d 658 to 1275 1 to 618     Submitted on the opposite strand 618/618
(100 %)
7 diff
(98.9 %id)
CR987977 T-Lymphocytes .d 660 to 1245 1 to 586       586/588
(99 %)
4 diff
(99.4 %id)
BG424809 Kidney, renal cell adenocarcinoma .d 671 to 1317 1 to 649       649/649
(100 %)
8 diff
(98.8 %id)
CN357996 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 678 to 997 1 to 320       320/320
(100 %)
1 diff
(99.7 %id)
CN357998 embryonic stem cells, cell lines H1, H7, andH9 .d 679 to 1041 1 to 363       363/363
(100 %)
0 diff
(100 %id)
BP872318 embryonal kidney .d 679 to 1256 1 to 581       581/581
(100 %)
7 diff
(98.8 %id)
BE387209 melanotic melanoma, skin .d 679 to 1281 57 to 679       618/685
(90 %)
45 diff
(93.5 %id)
BF002879 Prostate .d 690 to 952 12 to 278     Submitted on the opposite strand 267/278
(96 %)
6 diff
(97.9 %id)
AA760791 germinal center B cell .d 705 to 1066 1 to 362     Submitted on the opposite strand 362/362
(100 %)
9 diff
(97.6 %id)
DB453665 testis .d 732 to 1232 1 to 501       501/502
(99 %)
1 diff
(99.9 %id)
CO245964 Chondrosarcoma Lung Metastasis cell lines, lung .d 768 to 1389 1 to 620       620/812
(76 %)
14 diff
(98.3 %id)
BF984839 duodenal adenocarcinoma, cell line, small intestine .d 781 to 1484 1 to 702       702/777
(90 %)
18 diff
(97.7 %id)
BU500183   .d 781 to 1656 12 to 892   tiling clone,   881/903
(97 %)
19 diff
(97.9 %id)
BG661326 Islets of Langerhans, Pancreas .e 1 to 591 1 to 591   tiling clone,   591/591
(100 %)
2 diff
(99.7 %id)
BI199708 brain, neuroblastoma .e 130 to 960 1 to 837       837/837
(100 %)
29 diff
(96.6 %id)
BE260182 brain, neuroblastoma .e 149 to 730 1 to 584   tiling clone,   584/587
(99 %)
6 diff
(99.0 %id)
BE312303 brain, neuroblastoma .e 149 to 682 1 to 534       534/534
(100 %)
0 diff
(100 %id)
BF568110 epithelioid carcinoma cell line, Pancreas .e 655 to 1453 1 to 828   tiling clone,   828/988
(83 %)
15 diff
(98.5 %id)
BQ707019 Spleen .f-u 1 to 833 10 to 850   tiling clone,   848/968
(87 %)
20 diff
(98.0 %id)
TI_154195750   .f-u 309 to 1110 68 to 864       797/1019
(78 %)
48 diff
(95.3 %id)
BG329088 eye, retinoblastoma .f-u 310 to 1100 1 to 783       783/783
(100 %)
31 diff
(96.1 %id)
BG472912 eye, retinoblastoma .f-u 310 to 1054 1 to 760       760/760
(100 %)
29 diff
(96.2 %id)
BG474185 eye, retinoblastoma .f-u 310 to 784 1 to 476       476/476
(100 %)
4 diff
(99.2 %id)
BE900626 choriocarcinoma, placenta .f-u 316 to 972 14 to 662       649/961
(67 %)
19 diff
(98.1 %id)
CT002226 T-Lymphocytes .f-u 319 to 868 1 to 550       550/550
(100 %)
3 diff
(99.5 %id)
BE251705 eye, retinoblastoma .f-u 330 to 1033 1 to 702       702/756
(92 %)
8 diff
(99.0 %id)
BG831146 epithelioid carcinoma cell line, Pancreas .f-u 341 to 1105 1 to 766       766/766
(100 %)
5 diff
(99.4 %id)
TI_154195732   .f-u 368 to 1139 22 to 788       767/1031
(74 %)
25 diff
(97.6 %id)
BU196575 melanotic melanoma, cell line, skin .f-u 482 to 1149 22 to 689   tiling clone,   668/848
(78 %)
2 diff
(99.8 %id)
BQ680701 melanotic melanoma, cell line, skin .f-u 486 to 1154 1 to 671   tiling clone,   671/916
(73 %)
10 diff
(99.0 %id)
BQ682090 melanotic melanoma, cell line, skin .f-u 486 to 780 1 to 295       295/295
(100 %)
0 diff
(100 %id)
BQ680772 melanotic melanoma, cell line, skin .f-u 486 to 1155 1 to 673       673/898
(74 %)
13 diff
(98.6 %id)
AK096791 Prostate .g 1 to 1957 1 to 1957 R198G tiling clone, available from FLJ,   1957/1957
(100 %)
1 diff
(100.0 %id)
DA875134 Prostate .g 2 to 553 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
CD242427 brain, Pituitary .g 661 to 1223 7 to 574   tiling clone,   568/967
(58 %)
9 diff
(99.1 %id)
BM715079 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .g 956 to 1102 1 to 147     Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 147/147
(100 %)
1 diff
(99.4 %id)
BF372128 prostate_tumor .g 1123 to 1400 283 to 9       275/283
(97 %)
0 diff
(100 %id)
BU739985 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .g 1341 to 1957 636 to 20   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 617/618
(99 %)
0 diff
(100 %id)
DB330105 Prostate .g 1422 to 1957 537 to 1       537/537
(100 %)
1 diff
(99.9 %id)
AA808524 carcinoid, lung .g 1465 to 1956 492 to 1       492/492
(100 %)
0 diff
(100 %id)
BF435361 pooled .g 1486 to 1962 477 to 1   tiling clone,   477/477
(100 %)
1 diff
(99.8 %id)
AW593272 pooled .g 1488 to 1959 472 to 1       472/472
(100 %)
3 diff
(99.4 %id)
T06043   .g 1518 to 1828 312 to 1       312/312
(100 %)
2 diff
(99.4 %id)
AW130650 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .g 1527 to 1957 431 to 1       431/431
(100 %)
3 diff
(99.4 %id)
BF435997 pooled .g 1617 to 1962 348 to 3       346/348
(99 %)
0 diff
(100 %id)
BM805408 brain, hippocampus .h 1 to 902 24 to 929   tiling clone,   906/1081
(83 %)
19 diff
(98.3 %id)
TI_57184184   .h 289 to 1061 33 to 823       724/829
(87 %)
42 diff
(95.0 %id)
BI767944 pooled lung and spleen .h 290 to 1061 1 to 790       723/796
(90 %)
39 diff
(95.2 %id)
CR999350 T-Lymphocytes .h 396 to 1110 1 to 717       717/720
(99 %)
3 diff
(99.6 %id)
BG336302 choriocarcinoma, placenta .h 437 to 1225 1 to 789 L170W R171A F172S I173S H174T ... tiling clone,   789/1077
(73 %)
20 diff
(98.2 %id)
CN390153 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 476 to 1169 1 to 695   tiling clone,   695/695
(100 %)
2 diff
(99.8 %id)
BG473667 eye, retinoblastoma .h 476 to 1206 1 to 731   tiling clone,   731/731
(100 %)
5 diff
(99.4 %id)
CB154988 brain .h 494 to 1134 1 to 641   tiling clone,   641/641
(100 %)
0 diff
(100 %id)
BX281666 melanotic melanoma, skin .h 594 to 1071 1 to 478       478/478
(100 %)
0 diff
(100 %id)
CN390158 embryonic stem cells, cell lines H1, H7, andH9 .i 1 to 576 12 to 587   tiling clone,   576/587
(98 %)
6 diff
(99.0 %id)
CN390157 embryonic stem cells, cell lines H1, H7, andH9 .i 173 to 579 1 to 407       407/407
(100 %)
4 diff
(99.1 %id)
CN390162 embryonic stem cells, cell lines H1, H7, andH9 .i 197 to 843 9 to 656       648/656
(98 %)
7 diff
(99.0 %id)
CN390149 embryonic stem cells, cell lines H1, H7, andH9 .i 214 to 826 1 to 613       613/613
(100 %)
0 diff
(100 %id)
BP353036   .i 554 to 1147 1 to 594   tiling clone,   594/594
(100 %)
0 diff
(100 %id)
BP353060   .i 554 to 1130 1 to 577       577/583
(98 %)
1 diff
(99.9 %id)
DA516049 brain .j 1 to 540 2 to 542   tiling clone, capped   541/541
(100 %)
3 diff
(99.5 %id)
CF129133 Chondrosarcoma Lung Metastasis cell lines, lung .j 385 to 949 1 to 565       565/565
(100 %)
0 diff
(100 %id)
TI_154190699   .j 385 to 956 51 to 622   tiling clone,   572/1018
(56 %)
3 diff
(99.8 %id)
BF957833 nervous_normal .j 689 to 1032 1 to 347   tiling clone,   347/351
(98 %)
25 diff
(92.9 %id)
BM995919 lung, Metastatic Chondrosarcoma .k 1 to 566 584 to 19 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 566/566
(100 %)
0 diff
(100 %id)
DB512158 testis .l 1 to 426 2 to 427 exact tiling clone, Submitted on the opposite strand 427/427
(100 %)
1 diff
(99.8 %id)
BX437444 thymus .m 1 to 864 8 to 870   tiling clone,   863/870
(99 %)
6 diff
(99.4 %id)
DW410624 Liver .m 371 to 687 333 to 17   tiling clone,   317/333
(95 %)
0 diff
(100 %id)
BX437443 thymus .m 1082 to 2019 937 to 1   tiling clone,   937/937
(100 %)
2 diff
(99.8 %id)
CN390146 embryonic stem cells, cell lines H1, H7, andH9 .n 1 to 652 1 to 653 C101S tiling clone,   653/653
(100 %)
8 diff
(98.8 %id)
R63774 placenta .o 1 to 323 10 to 332 Y2D H12T K13S S14R T15L ... tiling clone, fully sequenced,   323/332
(97 %)
10 diff
(97.0 %id)
R64546 placenta .o 6 to 408 1 to 408   tiling clone,   408/422
(96 %)
23 diff
(94.6 %id)
BQ025785 placenta .o 151 to 619 485 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 469/469
(100 %)
0 diff
(100 %id)
BQ026230 placenta .o 269 to 619 366 to 16   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 351/351
(100 %)
1 diff
(99.8 %id)
R63725 placenta .o 297 to 617 320 to 1   fully sequenced,   320/320
(100 %)
5 diff
(98.5 %id)
DB461448 testis .p 1 to 495 1 to 495 exact tiling clone,   495/495
(100 %)
0 diff
(100 %id)
BC047335 Cervix, carcinoma .q 1 to 649 1 to 649 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 649/649
(100 %)
0 diff
(100 %id)
BI253724 cervical carcinoma cell line, cervix .q 3 to 672 1 to 672   available from MGC,   672/687
(97 %)
19 diff
(97.3 %id)
DB485279 hypothalamus .q 230 to 691 1 to 462       462/462
(100 %)
6 diff
(98.8 %id)
BU568417 testis .q 238 to 649 1 to 412       412/755
(54 %)
4 diff
(99.5 %id)
AV745053 cord Blood .q 240 to 518 1 to 272       277/281
(98 %)
9 diff
(96.8 %id)
AJ712966 bone marrow .q 241 to 660 11 to 432       422/432
(97 %)
7 diff
(98.4 %id)
AI264058 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q 247 to 669 425 to 3       423/425
(99 %)
1 diff
(99.8 %id)
DW419069 Liver .q 250 to 648 10 to 409       400/409
(97 %)
7 diff
(98.3 %id)
TI_158432884   .q 251 to 680 525 to 96   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 430/844
(50 %)
2 diff
(99.8 %id)
CF528661 placenta .q 251 to 680 449 to 20   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 430/436
(98 %)
2 diff
(99.6 %id)
AI807342 pooled .q 253 to 672 423 to 4       420/423
(99 %)
0 diff
(100 %id)
AA400692   .q 255 to 639 1 to 384       384/384
(100 %)
1 diff
(99.8 %id)
AA626161   .q 255 to 672 420 to 4       417/420
(99 %)
1 diff
(99.8 %id)
BQ185837 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .q 267 to 673 1 to 407   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 407/407
(100 %)
1 diff
(99.8 %id)
AI246365 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .q 268 to 671 404 to 1       404/404
(100 %)
0 diff
(100 %id)
AI124080 heart .q 277 to 671 395 to 1       395/395
(100 %)
1 diff
(99.8 %id)
BC063510 Eye, retinoblastoma .q 288 to 1463 1 to 1174   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 1174/1174
(100 %)
2 diff
(99.9 %id)
CA314374 Human Lung Epithelial cells, lung .q 298 to 665 368 to 1       368/377
(97 %)
3 diff
(99.3 %id)
AA906202 pooled .q 302 to 669 374 to 7       368/387
(95 %)
2 diff
(99.5 %id)
BE781734 eye, retinoblastoma .q 309 to 1025 1 to 713   available from MGC,   713/926
(76 %)
69 diff
(92.6 %id)
AA969154 pooled .q 331 to 669 339 to 1       339/339
(100 %)
1 diff
(99.8 %id)
AA976773 pooled germ cell tumors .q 338 to 669 346 to 15   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 332/332
(100 %)
1 diff
(99.7 %id)
AA894926 Kidney .q 346 to 669 331 to 8       324/331
(97 %)
0 diff
(100 %id)
AJ346049 pectoral muscle (after mastectomy) .q 349 to 666 1 to 318   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 318/322
(98 %)
2 diff
(99.4 %id)
AW087479 pooled .q 354 to 669 323 to 8       316/323
(97 %)
0 diff
(100 %id)
AW004773 colon .q 369 to 669 316 to 16   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 301/303
(99 %)
0 diff
(100 %id)
BQ184154 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .q 369 to 673 321 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 305/305
(100 %)
1 diff
(99.7 %id)
BQ011379 placenta .q 379 to 680 322 to 21   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 302/304
(99 %)
0 diff
(100 %id)
CA311140 Human Lung Epithelial cells, lung .q 421 to 665 245 to 1       245/245
(100 %)
3 diff
(98.8 %id)
BU589224 mixed (pool of 40 RNAs) .q 436 to 673 1 to 238   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 238/240
(99 %)
4 diff
(98.4 %id)
FN091387 breast carcinoma .q 471 to 566 1 to 97       97/98
(98 %)
2 diff
(98.0 %id)
FN091303 breast carcinoma .q 477 to 565 90 to 1     Submitted on the opposite strand 90/91
(98 %)
1 diff
(99.0 %id)
BQ012280 placenta .q 522 to 682 176 to 16   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 161/161
(100 %)
1 diff
(99.4 %id)
DB554303 hypothalamus .q 978 to 1426 1 to 449     Submitted on the opposite strand 449/449
(100 %)
8 diff
(98.3 %id)
BX099937 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .q 1011 to 1426 429 to 15   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 415/415
(100 %)
1 diff
(99.8 %id)
AI368527 anaplastic oligodendroglioma, brain .q 1018 to 1429 417 to 7       411/473
(86 %)
0 diff
(100 %id)
H67176 nose, olfactory epithelium .q 1102 to 1410 1 to 309   fully sequenced,   309/309
(100 %)
4 diff
(98.8 %id)
AI560533 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .q 1144 to 1428 284 to 1       284/284
(100 %)
1 diff
(99.7 %id)
AI692342 carcinoid, lung .q 1157 to 1429 275 to 4       272/275
(98 %)
0 diff
(100 %id)
H67855 nose, olfactory epithelium .q 1160 to 1401 251 to 1   fully sequenced,   251/251
(100 %)
5 diff
(98.1 %id)
H67761 liver and spleen .r 1 to 464 1 to 475 exact tiling clone,   475/490
(96 %)
14 diff
(97.2 %id)
BF223264 pooled germ cell tumors .r 331 to 715 482 to 98   tiling clone,   385/482
(79 %)
0 diff
(100 %id)
H67762 liver and spleen .r 925 to 1271 366 to 6   tiling clone,   361/430
(83 %)
18 diff
(95.9 %id)
BX365108 Placenta Cot 25-normalized .s 1 to 736 15 to 748 C19X tiling clone,   734/748
(98 %)
6 diff
(99.2 %id)
BI560707 testis .s 137 to 657 1 to 522 P24A T34S     522/655
(79 %)
10 diff
(98.5 %id)
TI_44349697   .s 142 to 657 87 to 603 P24A T34S     517/736
(70 %)
12 diff
(98.4 %id)
BG722300 testis .t 1 to 618 1 to 624 P24S tiling clone,   622/624
(99 %)
12 diff
(98.1 %id)
DB447003 testis .u 1 to 424 1 to 424 exact tiling clone,   424/424
(100 %)
3 diff
(99.3 %id)
DA099274 cerebellum .u 60 to 612 2 to 554 exact tiling clone, capped   553/553
(100 %)
0 diff
(100 %id)
DB462393 testis .va 1 to 472 1 to 472 exact tiling clone,   472/472
(100 %)
0 diff
(100 %id)
T61496 ovary .vb-u 1 to 135 134 to 1 C35X V36S N37T P38L T39X ... tiling clone,   134/134
(100 %)
1 diff
(99.3 %id)
AU157496 placenta Gene DHX30, variant not shown         Suspected internal deletion, this clone was ignored    
AU138167 placenta Gene DHX30, variant not shown       capped Suspected internal deletion, this clone was ignored    
288 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI